Gene editing brings new hope to GD's β-thalassemia major patients
Recently, Xiaolin (assumed name), a child with β-thalassemia major who had to receive monthly blood transfusions and daily medication, has been discharged from Sun Yat-sen Memorial Hospital and is expected to stop taking medicine.
2023-08-04 19:16:35